What is TRIL stock price today?

View the current TRIL stock price, daily change, and comprehensive market data on our real-time stock dashboard powered by Polygon.io.

How to analyze Trillium Therapeutics Inc stock?

Analyze Trillium Therapeutics Inc stock using key metrics like P/E ratio, EPS, dividend yield, market cap, revenue growth, and price performance charts available on our dashboard.

What are TRIL key financial metrics?

Key TRIL financial metrics include current stock price, P/E ratio, EPS, dividend yield, market capitalization, 52-week high/low, daily trading volume, and financial health indicators.

TRIL Stock Analysis

Trillium Therapeutics Inc - Real-time stock metrics, market data, and comprehensive analysis

Member SIPC.

Low Commissions

Learn More

Trillium Therapeutics Inc

Trillium is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. Our two clinical programs, TTI-622 and TTI-621, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune system.

Market Data

Current Price

$20.73

+$0.48 (2.35%)

Market Cap

-

Total Company Value

Day Range

$20.56 - $20.74

Session Volume

-

Last session total

Valuation Metrics

P/E Ratio

-

Price ÷ Earnings

EPS (Basic)

-

Earnings Per Share

Price-to-Book

-

Market Value ÷ Book Value

Financial Health

Revenue (TTM)

-

Trailing 12 Months

Net Income (TTM)

-

Profit After Tax

Gross Margin

-

Revenue Efficiency

Returns & Dividends

Dividend Yield

-

Annual Dividend ÷ Price

Annual Dividend

-

Per Share

Payout Ratio

-

Dividend ÷ EPS

Price Performance

Price Chart

1D 5D 1M 3M 6M 1Y 5Y 10Y

All times are in Eastern Time (ET)

Recent News

No news available

Data Source: Financial data is sourced from SEC filings via Tiingo and may be delayed. Market Status: CLOSED - Showing latest available data. (Last updated: 3:31 PM)
Logos provided by Logo.dev